手性化学试剂是指含有一个或多个不对称中心,在分子结构中至少有一个碳原子与四个不同的基团相连的有机化合物。这些不对称中心赋予了化合物旋光活性,导致它们具有左旋和右旋两种形式(即对映体)。在化学反应中,不同构型的手性试剂可以引发立体选择性的反应,从而形成单一立体异构体产物。
手性化学试剂在药物合成、催化过程、分析化学等多个领域都有着广泛的应用。例如,在药物研发过程中,许多活性成分因其具有手性结构而可能产生不同的生物效应,因此需要通过精确控制使用的手性试剂来确保最终产品的纯度和药效。此外,在催化剂的设计中,选择合适的手性配体或辅剂也能够显著提高反应的选择性和效率。
合成手性化学试剂的方法包括但不限于不对称合成、利用天然产物作为起始原料进行衍生化以及采用生物催化手段等。随着研究的深入和技术的发展,人们对于手性分子的认识越来越深刻,这也促进了相关领域的快速发展和进步。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(1R,5S,6R)-3-氮杂双环[3.1.0]己烷-6-甲醇 | ((1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl)methanol | 827599-22-4 | C6H11NO |
|
(1R)-(-)-10-樟脑磺哑嗪 | (-)-(camphoryl)sulfonyl oxaziridine | 104372-31-8 | C10H15NO3S |
|
(-)-文斯内酯 | (-)-2-azabicyclo[2.2.1]hept-5-en-3-one | 79200-56-9 | C6H7NO |
|
(+)-8,8-二氯樟脑磺哑嗪 | (+)-(8,8-dichlorocamphorylsulfonyl)oxaziridine | 127184-05-8 | C10H13Cl2NO3S |
|
—— | (S)-1-Phenylethane-1,2-diyl bis(4-(trans-4-pentylcyclohexyl)benzoate) | 165660-09-3 | C44H58O4 |
|
—— | 2102502-56-5 | C8H13NO2.ClH |
|
|
—— | (R)-(-)-4-[trans-4-(trans-4-propylcyclohexyl)cyclohexyl]-1-(1-methylheptyloxy)-2,6-difluorobenzene | 159077-75-5 | C29H46F2O |
|
—— | Exo-3-(Boc-amino)-8-azabicyclo[3.2.1]octane | 132234-68-5 | C12H22N2O2 |
|
—— | (S)-1,1'-spirobiindane-7,7'-diol | 223137-87-9 | C17H16O2 |
|
—— | hydrobenzoin | 492-70-6 | C14H14O2 |
|
—— | [(1S,5R)-3-azabicyclo[3.1.0]hexan-6-yl]methanol | 134575-13-6 | C6H11NO |
|
—— | (7S)-8,8-Dichloro-9,9-dimethyltetrahydro-4a,7-methano-3lambda~6~-oxazireno[3,2-i][2,1]benzothiazole-3,3(4H)-dione | 127184-05-8 | C10H13Cl2NO3S |
|
—— | (1S)-(+)-(Camphorylsulfonyl)oxaziridine | 104322-63-6 | C10H15NO3S |
|
—— | Dibenzoyl-L-tartaric acid monohydrate | 2743-38-6 | C18H16O9 |
|
—— | (+)-camphorsulfonyloxaziridine | 104372-31-8 | C10H15NO3S |
|
—— | 7,7-Dichloro-11,11-dimethyl-5-oxa-3lambda6-thia-4-azatetracyclo[6.2.1.01,6.04,6]undecane 3,3-dioxide | 127184-05-8 | C10H13Cl2NO3S |
|
—— | (1S,2S,5S)-2-(Hydroxymethyl)-5-vinylquinuclidine | 207129-35-9 | C10H17NO |
|
—— | hexahydrocyclopenta[c]pyrrol-5(1H)-one | 1257389-95-9 | C7H11NO |
|
—— | Hydroquinine 1,4-phthalazinediyl diether | 140924-50-1 | C48H54N6O4 |
|
—— | (Z,E)-9.12-Octadecadienalkohol | 506-43-4 | C18H34O |
|
—— | 1-((1R)-((2R,4R,5S)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)-4-((1R)-((2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)phthalazine | 140924-50-1 | C48H54N6O4 |
|
—— | (2S,8aR)-(-)-(Camphorylsulfonyl)oxaziridine | 104372-31-8 | C10H15NO3S |
|
—— | 1,4-Bis((1R)-((1S,2S,4S)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)phthalazine | 140924-50-1 | C48H54N6O4 |
|
—— | (1R)-(-)-(10-camphorsulfonyl)oxaziridine | 104372-31-8 | C10H15NO3S |
|
—— | (1S)-(+)-(10-camphorsulfonyl)oxaziridine | 104322-63-6 | C10H15NO3S |
|
—— | (1R,2S')-α-(pyrrolidin-2-yl)benzyl alcohol | 885462-68-0 | C11H15NO |
|
—— | (4As,8as)-9,9-dimethyltetrahydro-4h-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide | 104372-31-8 | C10H15NO3S |
|
—— | (-)-O,O′-dibenzoyl-L-tartaric acid monohydrate | 62708-56-9 | C18H14O8*H2O |
|
—— | O,O'-dibenzoyl-D-tartrate | 62708-56-9 | C18H12O8 |
|
—— | tert-butyl (R)-3-hydroxybutanoate | 110171-06-7 | C8H16O3 |
|
—— | pentane-2,4-diol | 72345-23-4 | C5H12O2 |
|
—— | (1R,5S)-bicyclo[3.1.0]hexan-2-one | 58001-78-8 | C6H8O |
|
—— | trans-Cyclohexane-1,4-diol | 6995-79-5 | C6H12O2 |
|
—— | dimethyl meso-tartrate | 608-69-5 | C6H10O6 |
|
—— | anhydroerythritol | 4358-64-9 | C4H8O3 |
|
—— | rac-tartaric acid dibenzoate | 93656-02-1 | C18H14O8 |
|
—— | 9,12-octadecadien-1-ol | 1577-52-2 | C18H34O |
|